What is the recommended dosage of botulinum toxin (Botox) for frontalis muscle treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Botulinum Toxin Dosage for Frontalis Muscle Treatment

The recommended dosage for botulinum toxin treatment of the frontalis muscle is 20 Units of onabotulinumtoxinA, administered as 4 Units (0.1 mL) into each of 5 sites across the forehead area. 1

Anatomical Considerations and Injection Technique

Optimal Injection Sites

  • Lower Treatment Row: Position injections midway between the superior margin of frontalis activity and the eyebrow, at least 2 cm above the eyebrow
  • Upper Treatment Row: Position injections midway between the superior margin of frontalis activity and lower treatment row

Specific Injection Points

  • Place 5 injections at the intersection of the horizontal treatment rows with these vertical landmarks:
    • On the lower treatment row at the midline of the face
    • 0.5-1.5 cm medial to the palpated temporal fusion line (temporal crest) on each side
    • On the upper treatment row, midway between the lateral and medial sites on the lower treatment row (both sides)

Safety Precautions

  • Maintain at least 2 cm distance above the eyebrow to prevent brow ptosis
  • Ensure proper identification of the superior margin of frontalis activity (approximately 1 cm above the most superior forehead crease)
  • Administer injections with the needle perpendicular to the skin surface

Dosage Adjustments Based on Treatment Combinations

When treating the frontalis muscle in combination with other facial areas:

  1. Frontalis alone: 20 Units total
  2. Frontalis with glabellar lines: 40 Units total (20 Units for forehead, 20 Units for glabellar)
  3. Frontalis with glabellar and lateral canthal lines: 64 Units total (20 Units for forehead, 20 Units for glabellar, 24 Units for lateral canthal)

Anatomical Variations and Personalization

The frontalis muscle shows significant anatomical variation across patients, which affects treatment outcomes 2, 3:

  • Forehead width: For wide foreheads (>70mm glabella-hairline distance), consider applying the toxin in three vertical lines in two split doses
  • Forehead height: For narrow foreheads (<60mm glabella-hairline distance), consider applying the toxin in three horizontal lines in two split doses 4

Administration and Handling Precautions

  • Healthcare providers should have epinephrine and antihistamine treatments available during administration
  • Ensure proper storage at 2°C to 8°C (36°F-46°F) in the original carton to protect from light
  • Do not freeze or shake the product 5
  • Observe patients during administration as the risk of anaphylaxis is <2%

Potential Complications and Prevention

To minimize the risk of complications:

  • Avoid injection near the levator palpebrae superioris
  • Place lateral injections at least 1 cm above the bony supraorbital ridge
  • Do not inject closer than 1 cm above the central eyebrow
  • Keep injected volume/dose accurate and minimal where feasible 1

Expected Outcomes

  • Chemical denervation typically begins 1-2 days after injection
  • Maximum effect develops during the first week
  • Duration of effect is approximately 3-4 months 1
  • Treatment efficacy should be assessed by the patient's ability to activate the superficial muscles injected

The frontalis muscle requires careful assessment before treatment to achieve optimal cosmetic results while minimizing complications. The recommended 20 Units dosage provides an effective starting point, with adjustments based on individual anatomical variations and treatment goals.

References

Research

A personalized treatment approach of frontalis muscle with botulinum toxin A (Bont-A) related to functional anatomy: case studies.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2020

Guideline

Myobloc Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.